Take a look around.
News
Press Releases
July 17, 2019
Pyxis Oncology Founded by Longwood Fund with Financing Led by Bayer
Pyxis Oncology ('Pyxis'), a newly formed immuno-oncology company, launched today with a focus on developing a new family of antibody-based immunotherapies derived from novel insights into the...
Learn moreJuly 15, 2019
FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease
Bayer announced today the U.S. Food and Drug Administration (FDA) has approved Gadavist® (gadobutrol) injection for use in cardiac magnetic resonance (MR) imaging to assess myocardial perfusion...
Learn more
